序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
61 Prebiotic compositions US12838741 2010-07-19 US08241658B2 2012-08-14 Glenn R. Gibson; Sofia Kolida
The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhea and constipation.
62 FOOD COMPOSITIONS COMPROMISING DRIED PROBIOTICS, METHODS OF MANUFACTURE AND USES THEREOF US12732314 2010-03-26 US20100247712A1 2010-09-30 Marvin J. Rudolph
The present invention is directed to a food composition including an edible base mix component and a dried probiotic component which that may be stored at room temperature and converted to a frozen dessert with minimal effects to the viability of probiotics. Accordingly, a consumer ingesting the frozen dessert is provided with a beneficial amount of viable probiotics. Also provided herein are one or more methods for manufacturing the food compositions and using the subject food composition in frozen dessert products.
63 METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH US12091047 2006-10-06 US20090263537A1 2009-10-22 Joachim Schmitt; Gunther Boehm
The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides
64 HUMAN MILK OLIGOSACCHARIDES TO PROMOTE GROWTH OF BENEFICIAL GUT BACTERIA US12121683 2008-05-15 US20090098240A1 2009-04-16 David A. Mills; Carlito B. Lebrilla; Riccardo LoCascio; Milady Ninonuevo; J. Bruce German; Samara Freeman
The present invention provides prebiotic and probiotic compositions containing human milk oligosaccharides and methods of use that selectively promote the growth of beneficial gut bacteria.
65 LACTOBACILLUS BIFIDUS GROWTH PROMOTING COMPOSITION AND USE THEREOF US09319268 1999-06-14 US20020015990A1 2002-02-07 MAMORU TOMITA; HIROTOSHI HAYASAWA; TOSHIO OHASHI; MITSUNORI TAKASE; HIROHIKO NAKAMURA; KOJI SAYAMA
A Lactobacillus bifidus growth promoting composition which significantly grows lactobacillus bifidus and does not produce any side effect such as diarrhea, and a blend comprising the above composition and other edible ingredients, and the composition comprises at least one oligosaccharide selected among lactulose, fructo-oligosaccharide, and galacto-oligosaccharide, and raffinose as the active ingredients.
66 Nutritional formulations containing lacto-N-neotetraose US273137 1999-03-19 US6083934A 2000-07-04 Pedro A. Prieto; Terry A. Kroening
A nutritional formulation containing an effective amount of Lacto-N-neoTetraose to simulate the growth and/or metabolic activity of Bifidobacterium is provided. A process of inhibiting bacterial infections caused by Bacteroides, Clostridium, and E. coli including the step of feeding the nutritional composition to a subject is also provided.
67 Nutritional formulations containing Lacto-N-neoTetraose US829220 1997-03-31 US5906982A 1999-05-25 Pedro A. Prieto; Terry A. Kroening
A nutritional formulation containing an effective amount of Lacto-N-neoTetraose to simulate the growth and/or metabolic activity of Bifidobacterium is provided. A process of inhibiting bacterial infections including the step of feeding the nutritional composition to a subject is also provided.
68 Formulations for infant feeding US38777264 1964-08-05 US3274003A 1966-09-20 WILLIAM ZILLIKEN FREDERICK
69 Growth-promoting substances and their recovery US28300652 1952-04-18 US2786051A 1957-03-19 PAUL GYORGY; RICHARD KUHN; FRIEDRICH ZILLIKEN
70 Alcoholized chitin, process of preparation and food products containing the same US29032552 1952-05-27 US2783148A 1957-02-26 PAUL GYORGY; RICHARD KUHN; FRIEDRICH ZILLIKEN
71 Food compositions US28377352 1952-04-22 US2694640A 1954-11-16 PAUL GYORGY; RICHARD KUHN; FRIEDRICH ZILLIKEN
72 METHOD FOR STIMULATING THE INTESTINAL FLORA US14973166 2015-12-17 US20160100618A1 2016-04-14 Günther BOEHM; Bernd STAHL; Jan KNOL
The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants.
73 METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH US14846120 2015-09-04 US20160058806A1 2016-03-03 Joachim SCHMITT; Günther BOEHM; Christopher BEERMANN
The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides.
74 INFANT FORMULA WITH HIGH SN-2 PALMITATE AND OLIGOFRUCTOSE US14357625 2013-10-29 US20140323574A1 2014-10-30 Manjiang Yao; Kalathur S. Ramanujam; Martin Jon Kullen; Margaret Fitzgerald
An infant formula having a relatively high content of triglycerides having palmitic acid in the sn-2 position. The formula may include oligofructose. The formula may also include at least one omega 6 fatty acid and at least one omega 3 fatty acid. The formula may also have a relatively low protein content and an alpha-lactalbumin content similar to human milk The invention also includes a method for improving the stool consistency, increasing bifidobacteria in the colon, reducing potentially pathogenic bacteria in the colon and reducing calcium soaps in the stool of a formula-fed infant.
75 DAIRY BASED COMPOSITIONS WITH LOW LPS US14131813 2012-07-13 US20140234487A1 2014-08-21 Andries Dirk Siemensma; Ynte Piet de Vries; Anouk Leonie Feitsma; Paula Maria Leandro Garcia; Albert van der Padt
The present invention is directed to a method to produce a dairy based food composition with low LPS comprising the steps (a) Providing a milk with a storage time of less than 264 hours and either (b1) Treating the milk with a microfilter of poresize of from 0.01-2 μm such that at least a casein rich fraction and a serum protein rich fraction is obtained, or (b2) Treating the milk such that at least 98 wt % of the Gram negative bacteria is removed, and heating the milk wherein at least 98wt % of the Gram negative bacteria is removed to 60-90° C. The methods of the present invention are very suitable to provide a dairy based food composition wherein less than 5100 EU LPS per liter ready to use food composition is present or wherein less than 39 EU LPS per gram dry product is present.
76 Human milk oligosaccharides to promote growth of beneficial gut bacteria US12121683 2008-05-15 US08197872B2 2012-06-12 David A. Mills; Carlito B. Lebrilla; Riccardo LoCascio; Milady Ninonuevo; J. Bruce German; Samara Freeman
The present invention provides prebiotic and probiotic compositions containing human milk oligosaccharides and methods of use that selectively promote the growth of beneficial gut bacteria.
77 Process for Isolating Sialic Acid Containing Oligosaccharides, and the Compositions Containing Sialic Acid Containing Oligosaccharides Obtainable Thereby US12921474 2009-03-13 US20110098244A1 2011-04-28 Alfred Willy Bonte; Gijsbert Klarenbeek; Marcus Johannes Aloysius Becker
The invention relates to a process for isolating sialic acid containing oligosaccharides and in particular sialyllactose from a milk stream and especially from a whey stream. The process yields a product having a high content of sialyllactose and a low content of phosphorus compounds. This product is highly suitable to be included in infant foods.
78 METHOD OF IMPROVING SKILLS WITH A COMPOSITION COMPRISING NON-DIGESTIBLE SACCHARIDE US12531256 2007-03-13 US20100063002A1 2010-03-11 Bernd Stahl; Jan Knol
The present invention concerns a therapy aimed at language and/or social skills in infants through administration of components stimulating the development of a healthy intestinal flora.
79 METHOD FOR TREATING AND/OR PREVENTING INFECTIONS IN INFANTS DELIVERED VIA CAESAREAN SECTION US12091050 2006-10-06 US20090221486A1 2009-09-03 Joachim Schmitt; Bernd Stahl; Jan Knol
The present invention provides the use of a composition comprising uronic acid oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section.
80 PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION US12091011 2006-10-06 US20090220639A1 2009-09-03 Joachim Schmitt; Bernd Stahl; Jan Knol
The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section.
QQ群二维码
意见反馈